Enhancement of in-vitro GC (Glucocorticoid) function in patients with COPD [chronic obstructive pulmonary disease]. A randomised, double-blind, placebo controlled, parallel-group study to investigate the effect of theophylline and fluticasone on induced sputum cells obtained from COPD patients
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Theophylline (Primary) ; Fluticasone propionate
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- 04 Dec 2019 Biomarkers information updated
- 18 Mar 2010 Results were published in Chest.
- 17 Sep 2007 Status changed from initiated to completed.